Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Zocor
Generic name / active ingredient
simvastatin
Dosage-form class
Simvastatin oral film-coated tablets: 10 mg, 20 mg and 40 mg (as listed in DailyMed SPL v11; this dossier separately displays three 30-tablet bottle panels)
Route
Oral
Record reviewed
2026-08-21

Copy from the pack in hand

Source-linked reading points

  • Check ZOCOR, simvastatin, the stated 10, 20 or 40 mg per tablet, oral-tablet form, actual package and target market together. Mg identifies this exact tablet; it is not a web answer to “how many today,” and it does not permit self-combining strengths or interchanging another statin.
  • The label contains a specific restriction for 80 mg. It must not be simplified into self-escalation, using leftovers, or converting from another statin to ZOCOR; any strength change needs a professional who knows the indication, current label and complete medicine list.
  • The label signals that some medicines, grapefruit juice and other exposure-affecting situations need review. Bring every lipid medicine, anti-infective, cardiovascular medicine, OTC product, herb and supplement with the actual packages to a pharmacist or clinician; different names do not prove the absence of overlap or interactions.
  • With unexplained muscle pain, tenderness or weakness—especially with fever, marked fatigue or dark urine or another severe symptom—use timely local medical support. Do not self-stop, change to atorvastatin/rosuvastatin, or add another lipid medicine from a webpage.

Reviewed presentation examples — compare every field

  • 10 mg per tablet; 30-tablet bottleNDC 78206-180-01
  • 20 mg per tablet; 30-tablet bottleNDC 78206-181-01
  • 40 mg per tablet; 30-tablet bottleNDC 78206-182-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-21
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image